Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
darunavir-cobicistat-emtricitabine-tenofovir alafenamide
darunavir-cobicistat-emtricitabine-tenofovir alafenamide
- Formulary
Last updated: Mar. 25, 2019
- Black Box Warning: Post Treatment Acture Exacerbation of Hepatitis B
Symtuza is formulary unrestricted. Inpatients are encouraged to use home supply. Symtuza may be obtained if patient's home supply is unavailable. Defer initiation to outpatient.
Reviewed: 27 Nov 2018 (Symtuza)